General activities
Goliver Therapeutics is a biotechnology company, spin-off from the Inserm and Nantes University, focused on developing novel stem cell-based therapies to address the high unmet medical need in liver transplantation. Goliver Therapeutics aims to deliver Advanced Therapy Medicinal Products (ATMP) from human pluripotent stem cells that promises to become a live-saving alternative to liver transplantation and to regenerate the own patient’s liver.
Terms of collaboration
☒ Research collaboration
☐ Service provision
☐ Material supply
☒ Co-development
☐ Other
Is affiliated to the cluster 